Breast cancer in Lebanon: Incidence and comparison to regional and Western countries

Lakkis, Najla A.; Adib, Salim M.; Osman, Mona; Musharafieh, None Umayya M.; Hamadeh, Ghassan

doi:10.1016/j.canep.2010.02.013

Cited by 66 publications

(78 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While the median age at diagnosis for women (52.5 years) (Lakkis et al, 2010), Iran (46 years) (Taheri et al, 2012), Australia (60 years) (Australian Institute of Health, 2012). An article from Arab countries describing that the presents of breast cancer almost 10 years younger than in the USA and European countries.…”

Section: Iraq and United Kingdom In 2009mentioning

confidence: 99%

“…A marked increase in the annual number of breast cancer among Iraqi women between 2000 and 2009, this most probably due to the improvement awareness in connection with the Iraqi National Breast Cancer Research Program that began in 2000, Improvement of Iraqi national cancer research center data collection, opening of new breast cancer screening mammograms that were implemented from 2000 onward led to increased mammography screening. In a report from Arab countries, show that the rising in incidence in Arab countries and the change may be due to a westernized life style including dietary habits, lack of exercise, delay of age of marriage, women have their diagnosis of breast cancer delayed because of lack of awareness, social customs and most important is a low index of suspicion from primary care (Saadat, 2008 (Lakkis et al, 2010), 44.5-47.15% in Jordan (Tarawneh et al 2009, Tarawneh et al 2011), Kuwait 47.5% (Al-Madouj et al, 2011, and less than those observed in UAE 56.7%,, Qatar 59.7%, Saudi 58.8(AlLibya (71%) (Boder et al, 2011), 74% Sudan (Elgaili et al, 2010), Iran 67.5% (Montazeri et al, 2008). An article from developing countries including Arab countries, show that breast cancer among women with a young age of around 50 years at presentation (El Saghir, et al, 2007).…”

Section: Iraq and United Kingdom In 2009mentioning

confidence: 99%

See 1 more Smart Citation

Breast Cancer in Iraq, Incidence Trends from 2000-2009

Al-Hashimi¹,

Wang²

2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

Section: Iraq and United Kingdom In 2009mentioning

confidence: 99%

Section: Iraq and United Kingdom In 2009mentioning

confidence: 99%

Breast Cancer in Iraq, Incidence Trends from 2000-2009

Al-Hashimi¹,

Wang²

2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…The main role of mammographic screening has been underlined recently by several researches, although prevention may play a vital role for future breast cancer control (Miller, 2011;Miller 2011a, p. 147). Lakkis et al (2010) show in Lebanon the high rate of incidence of breast cancer among women in comparison with other Arab countries and this result is attributable to wide implementation of screening program. Botha et al (2003) claim that countries with national screening programs have a decline of mortality such as in England and Wales (3.1%), Scotland (2%), The Netherlands (1%).…”

Section: Discussion On Socio-economic Determinants Of Breast Cancer Imentioning

confidence: 97%

Breast cancer and socio-economic factors

Chagpar

Coccia

2012

Work Paper Public Hlth

View full text Add to dashboard Cite

Wealth. AbstractPurpose: The aim of this study is twofold -on the one hand, to analyze the relationship between incidence of breast cancer, income per capita and medical equipment across countries; after that, the study here discusses the drivers of the incidence of breast cancer across countries in order to pinpoint differences and similarities.Methods: The indicators used are incidence of breast cancer based on Age-standardized rate (ASW); Gross domestic product (GDP) per capita by purchasing power parity (current international $); computed tomography (CT) for cancer diagnosis. Results: Partial correlation is higher: r breast cancer, GDP  CT =60.3% (sign.0.00). The estimated relationship shows an expected incidence of breast cancer increase of approximately 0.05% for a GDP increase of 1% and an expected incidence of breast cancer increase of approximately 3.23% for a CT increase of 1%. ANOVA confirms that incidence of breast cancer is higher across richer countries, ceteris paribus.Conclusions: Empirical evidence shows that the breast cancer tends to be higher across richer countries, measured by GDP per capita and number of Computed Tomography.The main determinants of these findings can be due to several socio-economic factors, mainly localized in richer countries. In addition, this research may provide an alternative interpretation to the theory of Oh et al. (2010) on the influence of latitude on breast cancer, focusing on socio-economic factors rather than biologic root causes.

show abstract

“…It is also observed a decreasing trend occurred in incidence rates since 2003 due to the decreasing use of Hormone replacement therapy (HRT) [27]. Some authors suggest that lower breast cancer incidence rates in low-income (developing) countries probably reflect international variation in hormonal factors and problems in accessibility to early detection facilities [28] [29].…”

Section: Discussionmentioning

confidence: 99%

Modeling Breast Cancer Incidence Rates: A Comparison between the Components of Functional Time Series (FTS) Model Applied on Karachi (Pakistan) and US Data

Yasmeen¹

2016

OJAppS

View full text Add to dashboard Cite

Several studies showed that the breast cancer incidence rates are higher in high-income (developed) countries, due to the link of breast cancer with several risk factors and the presence of systematic screening policies. Some of the authors suggest that lower breast cancer incidence rates in low-income (developing) countries probably reflect international variation in hormonal factors and accessibility to early detection facilities. Recent studies showed that the breast cancer increased rapidly among women in Pakistan (a developing country) and it became the first malignancy among females of Pakistan. Although, the incidence rates may contain important evidence for understanding and control of the disease; however in Pakistan, the breast cancer incidence data have never been available in the last five decades since independence; rather, only hospital-based data are available. In this study, we intend to apply Functional Time Series (FTS) models to the breast cancer incidence rates of United State (developed country), and to see the difference between various components (age and time) of Functional Time Series (FTS) models applied independently on the breast cancer incidence rates of Karachi (Pakistan) and US. Past studies have already suggested that the incidence of US breast cancer cases was expected to increase in the coming decades. A progressive increase in the number of new cases is already predetermined by the high birth rate that occurred during the middle part of the century, and it will lead to nearly a doubling in the number of cases in about 4 decades. We also obtain 15 years predictions of breast cancer incidence rates in United States and compare them with the forecasts of incidence curves for Karachi. Development of methods for cancer incidence trend forecasting can provide a sound and accurate foundation for planning a comprehensive national strategy for optimal partitioning of research resources between the need for development of new treatments and the need for new research directed toward primary preventive measures.

show abstract

Breast cancer in Lebanon: Incidence and comparison to regional and Western countries

Cited by 66 publications

References 26 publications

Breast Cancer in Iraq, Incidence Trends from 2000-2009

Breast Cancer in Iraq, Incidence Trends from 2000-2009

Breast cancer and socio-economic factors

Modeling Breast Cancer Incidence Rates: A Comparison between the Components of Functional Time Series (FTS) Model Applied on Karachi (Pakistan) and US Data

Contact Info

Product

Resources

About